However, a study in glioblastoma found that neither hyperactivated AKT nor p53/Rb loss has an effect on the cellular sensitivity to JQ1 [23], indicating that PTEN status as predictive marker may be associated with certain types of cancer (such as endometrial cancer) and not others. The gene discussed is TP53; the disease is glioblastoma.